Search Results 1141-1150 of 16493 for Tic
Giant cell arteritis (GCA), formerly known as temporal arteritis, was first described by Mayo doctors and classified as an inflammatory condition of the blood ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
RIYADH, Saudi Arabia and ROCHESTER, Minn. — Saudi German Health (SGH), a leading healthcare provider and pioneer in advancing medical excellence across the ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
Page 1. Giudicessi, Noseworthy, Friedman, Ackerman. Mayo Clinic Proceedings 2020 (published online 03/25/2020)
At this time, there are no FDA approved medicines approved in the US for the prevention treatment of migraine headaches in children and adolescents.
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match ...
— Clinicians typically classify meningiomas — the most common type of brain tumor — into three grades, ranging from slow-growing to aggressive. But[...] ...
After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...
Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.